Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
Masashi Takawa(Kyorin University), Ryuji Hamamoto(RIKEN Center for Advanced Intelligence Project), Kazuhiro Maejima(RIKEN Center for Integrative Medical Sciences), Yukiko Iwai(The University of Tokyo), Yuka Yamane(The University of Tokyo), Gouji Toyokawa(University of Tokyo Hospital), Hyun‐Soo Cho(Korea Research Institute of Bioscience and Biotechnology), Katsunori Takagi(Nagasaki University), Takaaki Kobayashi(University of Kentucky), Masaki Kunizaki(Nagasaki University), Yusuke Nakamura(National Institute of Biomedical Innovation, Health and Nutrition), Takayuki Akasu(Imperial Household Agency), Masanori Sugiyama(University of Toyama), Bruce A.J. Ponder(University of Cambridge), Eijyu Tsuchiya(Kanagawa Prefectural Hospital Organization), Yutaka Atomi(Kyorin University), Ken Masuda(Hiroshima City Asa Citizens Hospital), Helen I. Field(Rockefeller University), Yataro Daigo(The University of Tokyo)
Cited by 191
Related Papers
Identification of FAP Locus Genes from Chromosome 5q21
|Science|1991|2.4k
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Somatic mutations of the <i>APC</i> gene in colorectal tumors: mutation cluster region in the <i>APC</i> gene
|Human Molecular Genetics|1992|934